Halozyme Therapeutics, Inc. (NASDAQ:HALO)
CAPS Rating:
A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.
RSS Headlines
Fool UK
Recs
Good things on th ehorizon for Halozyme
Turns out that was an ICBM you saw on the horizon.